A B S T R A C T A newly devised dual labeled iodine isotopic method is described for the detection and quantitation of alterations in thyroxine (T4) deiodination rate in man. This method employs the principle of a constant 'I infusion to serve as a reference source for the generation of 13I derived from the deiodination of T J-'I. Measurement of these two iodide isotopes are made in serially timed urine collections and are expressed in terms of a ratio value. Using this technique, it was possible to measure accurately the effects of a single dose of 6-propylthiouracil (6-PTU) in producing inhibition of T4 deiodination in euthyroid subjects. It was also possible to assess the time of onset, duration of action, and degree of inhibition produced by 6-PTU. Employing single doses of 6-PTU, ranging from 100 to 1000 mg, there was found to be a log dose relationship with a degree of inhibition observed in T4 deiodination. In control studies T4 deiodination rate was found to be constant for periods ranging up to 72 hr in normal ambulating subjects. The acute administration of many other agents was employed in an attempt to alter the T. deiodination rate. These included diphenylhydantoin, methimazole, triiodothyronine, thyroxine, thyroid stimulating hormone (TSH), adrenocorticotropin (ACTH), hydrocortisone, predinsolone, potassium iodide, epinephrine, and oxytocin. No detectable change in T4 deiodination rate was observed with these agents in the dosage ranges employed in this study. The lack of any observable alteration in the To deiodination rate in response to this array of drugs and hormones appears to indicate that the availability of T4 to intracellular sites of deiodination and possibly action is well modulated to resist abrupt changes. 
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INTRODUCTION
A number of recent studies have been directed toward the measurement of changes in thyroxine (T4) disposal rate in man in response to both thyroidal and nonthyroidal disease, as well as to a variety of pharmacological and physiological stimuli (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . The close correlation generally observed between T4 disposal rate and peripheral hormonal action would appear to underscore the importance of these studies (11) (12) (13) (14) (15) (16) . The majority of these investigations have relied primarily upon the determination of labeled T4 turnover rates in either the plasma or the whole body.
Since T4 disposal is the resultant of two rather distinct processes, i.e. (a) degradative deiodination and (b) biliary excretion, it would seem fundamental to the understanding of these previous studies to determine by which of the two routes To disposal was altered. This present investigation has been directed expressly at establishing a technique for the quantitative measurement of alterations in one of these mechanisms for thyroxine disposal, namely T4 deiodination rate. Additionally, the proposed method will allow measurement of the rapidity of onset, the duration of action, as well as the magnitude of changes in the T4 deiodination rate.
METHODS
Study subjects. The subjects in this investigation were hospitalized as inpatients at the Clinical Research Center of the Los Angeles County/University of Southern California Medical Center. They displayed no clinical or laboratory evidence of thyroid disease, but they did have incidental diseases such as peptic or gastric ulcer, mild chronic renal disease, and dietary-controlled diabetes mellitus. None of these subjects displayed proteinuria when studied. Patients were encouraged to ambulate freely and to alter as little as possible their normal living pattern during the testing period.
Materials. A pulse tracer dose of [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] votied it ap150xmlgsurinesecime virtually excluded from the urine in the absence of ntained 3 cc of IRA 400 anion exchange proteinuria as a result of its avid binding to the serum ycle, 20-50 mesh (Mallinckrodt Chemical T4 binding proteins. In contrast to T4, I which is proMo.). The resin was incubated with the duced from T4 deiodination was rapidly cleared into r period at room temperature to allow the the urine. This renal partitioning of substrate (T4) and labeled I to be concentrated in the resin samples were then decanted. Residual resin product (I) thus became a useful tool for assessing to a glass counting tube. Variations in the alterations in T4 deiodination. for each sample were equalized so as to During the preliminary phases of this investigation, an attempt was made to measure T4 deiodination rates without employing a dual tracer system. 3 days after the administration of a pulse tracer dose of T4-'9I, quantitative collections of serial-timed urines were performed. Thyroid uptake of labeled I was blocked during the study period by 10 drops of saturated solution of potassium I administered twice daily. Calculation of the excretion rate of the '31I in each sample, in terms of the percentage of the injected dose per hour, was then assessed. The results are plotted in Fig. 1 . In spite of the large variations in the hourly excretion rate of 131I, the mean daily values were observed to fall along a linear declining exponential slope which paralleled the labeled T4 activity in the plasma from which it was derived. Unfortunately there was no way, employing the single isotope approach, to distinguish whether the daily fluctuations resulted from alterations in renal iodide clearance and/or T4 deiodination rate.
The introduction of a constant infusion of 'I as a reference source for the I release from the deiodination of T4-131I served to resolve the problem of variation in renal I clearance. After equilibration of the T4 and I tracers in their respective extrathyroidal pools, any variation in the rate of T4 deiodination was then reflected as a change in the ratio of the two I isotopes as they passed into each urine sample. 24 and 72 hr in an attempt to ascertain whether spontaneous variations in T4 deiodination could be observed. No discernible alteration in the linearity of the urinary ratio slopes was found. Similar findings were obtained during the 12-36 hr interval incorporated as a control period in the studies where testing agents were employed.
The influence of 6-propyltliiouracil (6-PTU) on thyroxinte deiodination. 16 studies were performed on 11 subjects designed to explore the effects of a single orally-administered dose of 6-PTU on T4 deiodination. Fig. 2 portrays the results of one such study. During the initial 8 hr of this study, a precipitous drop in the urinary ratio slope was observed. This drop was a reflection of the infused "I approaching equilibration with the extrathyroidal I pool. The prolonged equilibration period resulted, in this instance, because no loading dose of 'I was employed. The 8-27 hr interval served as a control period for the evaluation of spontaneous variations in the T4 deiodination rate. Clearly, none were observed within the limits of sensitivity of the method. After 6-PTU was administered orally, a prompt decline in the "31I: 1I ratio slope was observed. This downward deflection represented a decrease in the generation of "3I resulting from T4 deiodination. After a 4 hr period, a reversal of the slope was seen. By 8 hr, after this single dose of 6-PTU, the ratio slope was observed to fall on the extrapolated control slope values. At 40 hr. the 12"I constant infusion was discontinued and the change in ratio values was followed for several hours in an effort to establish an I disappearance slope.
In the remaining 20 studies employing single 6-PTU doses, similar results were observed. The dosage range employed varied between 100 and 1000 mg of 6-PTU. After 6-PTU administration, the extrapolated "'nI: PI slope was always reestablished. This indicated that although substantial inhibition of deiodination had occurred there was no net alteration in the total T4 disposal rate after 6-PTU administration. This was confirmed when plasma T4-"'I activity was concomitantly determined as is shown in Fig. 2 .
The consistent manner of 6-PTU action, in abruptly depressing the 3I : 'I ratio slope, allowed analysis of the degree of this inhibition for any given administered dose. The method of analysis is based on the concept that if labeled T4 deiodination rate was inhibited completely the expected change in the slope of 181I: 'I ratio would be dependent upon the fractional rate of 'I clearance. This value (k) can be determined as follows: if k1 = the fractional rate of T4 disposal, k3 = the rising slope observed after 'I infusion is terminated, and k2 = the declining slope observed after 6-PTU administration, then it follows that k may be calculated as: k= k -k3 (1) Or in terms of half-life measurements this may be expressed as:
0.693 0.693 k = _~ (2) ti/2 t2/1 where ti/-= half-life of T4 disposal and t2/1 = time required for doubling of the ratio value above the projected control -ratio. where tiI/ = half-life of the decline in the ratio from the. (15) . Their prinr 6-PTU administration and k3 the slope after cipal objection concerned the assumptions that the T4 ig the 126I infusion.
pa betocoerethasu tintatheT and I tracers had similar extrathyroidal distribution t'i, and t2/1 values were directly determined spaces and that the I tracer had achieved an adequate lotted data for each study. This is diagramati-state of equilibration when the studies were performed. rated in Fig. 3 .
Correction for the differences in I and T4 pool sizes can ults of this form of analysis, on the subjects be employed, as was done by Levy, Marshall, and Sheeultsof this form pofranalysis on the. subjhect han (16) , but this adds greatly to the complexity of the eived 6-PTU, are portrayed in Fig. 4 .
Therethe use of a single pulse I tracer be a log dose inhibitory response of 6-PTU std.I diin h s o igepleItae may be associated with further inaccuracies. In the first dination rate over the dosage range employed. f h irger doses of 6-PTU were given, a somewhatfe horpotncin .hremybnnleatyf ir oses of inhiPitUon w.er gie, a soewh the I disappearance due to compartmental mixing. After 12 hr, the plasma I slope again appears to become non-6 hr. In contrast, when dosages were admin-linear suggesting a possible slowly equilibrating I pool isterea at hourly intervals over a IU hr period, a much longer period of inhibition of deiodination was produced (Fig. 5) .
Many drugs and hormonal substances were screened in a manner similar to that which was employed in the 6-PTU studies. The results are summarized in Table I . Methimazole (Tapazole), which has a similar action to 6-PTU in blocking iodine organification in the thyroid, had no effect on the peripheral deiodination of T4.
Diphenylhydantoin (Dilantin) likewise was without any effect even when administered at five times the daily therapeutic dose. The administration of triiodothyronine, thyroxine, iodides, thyrotropin, corticotropin, hydrocortisone, prednisolone, epinephrine, and oxytocin in varying dosage levels also caused no detectable acute alteration in thyroxine deiodination rate. or recycling from the alimentary tract (16) .. These problems, attendant with pulse-labeling, would appear to seriously jeopardize the usefulness of the technique described by Anbar, Guttman, Rodan, and Stein (15) and later modified by Levy, Marshall, and Sheehan (16) . This study clearly indicated that 6-PTU uniformly inhibited T4 deiodination (6, 7) . Although 6-PTU will cause an abrupt inhibition in T4 deiodination, other routes of T4 disposal appeared to be reciprocally augmented such that total serum T4 disposal rate was essentially unchanged. Apparently a marked augmentation in stool losses of labeled T4, as previously pointed out by Hershman (6) , virtually compensated for the decrease in urinary excretion. The observation that the extrapolated control 'I: I slope was reestablished after the dissipation of the 6-PTU drug effect, as illustrated in Fig. 2 lends some support to this conclusion. If this reciprocal relationship between deiodination and biliary excretion had not occurred, there would have been a net conservation of labeled To when 6-PTU was administered. This effect would have resulted, in turn, in a flattening out of the plasma disposal slope during the 6-PTU administration and an elevation of the urinary ratio slope above the extrapolated control slope after the withdrawal from the 6-PTU drug effect.
The major site of action of 6-PTU on the peripheral tissue alteration of T4 deiodination appears most likely to be the liver, although similar effects have been observed in kidney slices (18) . Since the liver contains deiodinating as well as conjugating enzyme systems for thyroxine, one may speculate that if the hepatic cells were unable to deiodinate T4 the alternative route of glucuronide conjugation and biliary excretion would then be utilized (19) . The demonstration that 6-PTU and other thiourea drugs alter liver size, oxygen uptake. and protein metabolism (20, 21) would lend credence to this speculation. Methimazole, a drug similar to 6-PTU in its antithyroid action, was not observed to inhibit peripheral T4 deiodination. These differences in' inhibitory action of 6-PTU and methimazole have been observed previously by many investigators in vivo and in vitro in laboratory animal experimentation (19) . It appears that the antithyroid activity and the inhibitory action on To deiodination of a variety of antithyroid drugs do not closely correlate (22) . This observation may indicate that these drugs act in some fundamentally different way in inhibiting perioxidase enzyme systems involved in T4 formation and deiodination. Another possibility is that the penetration of methimazole into an extrathyroidal site of action was not comparable to that found in the thyroid gland itself.
Although it was of great interest that 6-PTU did inhibit T4 deiodination, it was also apparent that in normal ambulating subjects, as well as in patients receiving a number of pharmacological and hormonal substances, T4 deiodination rate was remarkably constant (Table I) . This constancy may, in part, be a reflection of the modulating effect of the large pool of exthrathyroidal T4 bound to the specific circulating thyroxine-binding proteins.
It was surprising that such an agent as diphenylhydantoin did not alter T4 deiodination rate. Previous concepts of the action of diphenylhydantoin suggested that it should have displaced T4 from the serum T4 binding globulin and made it more available to intracellular deiodinating sites (23) (24) (25) (26) . This increased availability of T. to intracellular sites should have then resulted in a significant increase in the rate of T4 deiodination. Indeed, Oppenheimer, Bernstein, and Hasen have demonstrated that such an intracellular compartmental shift does occur in T4 distribution in man during the intravenous infusion of 150 mg of diphenylhydantoin (27) . Yet, at doses of 500 mg intravenously or 2000 mg orally. diphenylhydantoin could not be demonstrated to result in any detectable acute alteration in To deiodination rate in our studies. Resolution of these apparently disparate findings may be evident from the work of Mendoza, Flock, Owen, and Paris in the rat (28) . They (lemonstrated, both in the whole animal and in isolated liver infusion studies, that diphenylhydantoin does not acutely result in alterations in T4 deiodination rate, but when a pretreatment period of 3-13 day was employed, marked alterations in T4 metabolism could be observed. Recently, Chin and Schussler (29) have observed a significant lowering of "free" thyroxine values in some patients receiving diphenylhydantoin therapy which inferred a possible alteration in the feedback regulatory mechanisms for To secretion. It appears that the mode of action of diphenylhydantoin on thyroxine metabolism may be considerably more complex than has been previously realized.
Special note should possibly be made of the negative responses observed with epinephrine and glucocorticoid administration. In spite of previous conflicting data obtained from animal experimentation, recent work by Hays and Solomon has revealed little effect of chronic administration of epinephrine on peripheral T4 deiodination rate in man (30) . The present understanding of the action of glucocorticoids on thyroid hormone metabolism in experimental animals is also unclear (19) , but it appears that glucocorticoids do not significantly alter T4 disposal rate in man (31) . It should be emphasized that the negative responses to these agents should be considered in light of the limitation of the method to detect only acute alterations in T4 deiodination. Thus, it would not be possible to reflect changes which might have occurred over a longer time span. Moreover, the dosages of the agents used in this study may not have been adequate to elicit a positive response, although a broad dosage range of each agent was employed in an effort to meet this possibility.
There have been a number of investigations relating to serum "free" T4 as a major determinant of hormonal action (32) (33) (34) (35) (36) (37) (38) . Inherent in all of these studies is the concept that the "free" To measurement determined in vitro directly relates to the concentration of T4 at a hypothetical intracellular site of action. Recently, however, such a correlation has been questioned by Oppenheimer (39) . Although a variety of phenomena and agents are associated with changes in extracellular "free" T4 levels, there has been no way to determine whether these alterations result in a change in the amount of intracellular To available for hormonal action. It is anticipated that this presently described method for measuring changes in To deiodination will allow some insight into this problem by serving as an index for the intracellular availability of T4 to hormonal sites of action.
